BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18203332)

  • 1. CTGF polymorphism associated with systemic sclerosis.
    Gourh P; Mayes MD; Arnett FC
    N Engl J Med; 2008 Jan; 358(3):308-9; author reply 309. PubMed ID: 18203332
    [No Abstract]   [Full Text] [Related]  

  • 2. CTGF polymorphism associated with systemic sclerosis.
    Morita H; Hayashi D; Nagai R
    N Engl J Med; 2008 Jan; 358(3):308; author reply 309. PubMed ID: 18199873
    [No Abstract]   [Full Text] [Related]  

  • 3. A polymorphism in the CTGF promoter region associated with systemic sclerosis.
    Fonseca C; Lindahl GE; Ponticos M; Sestini P; Renzoni EA; Holmes AM; Spagnolo P; Pantelidis P; Leoni P; McHugh N; Stock CJ; Shi-Wen X; Denton CP; Black CM; Welsh KI; du Bois RM; Abraham DJ
    N Engl J Med; 2007 Sep; 357(12):1210-20. PubMed ID: 17881752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1.
    Holmes A; Abraham DJ; Chen Y; Denton C; Shi-wen X; Black CM; Leask A
    J Biol Chem; 2003 Oct; 278(43):41728-33. PubMed ID: 12888575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts.
    Leask A; Sa S; Holmes A; Shiwen X; Black CM; Abraham DJ
    Mol Pathol; 2001 Jun; 54(3):180-3. PubMed ID: 11376132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.
    Shi-wen X; Pennington D; Holmes A; Leask A; Bradham D; Beauchamp JR; Fonseca C; du Bois RM; Martin GR; Black CM; Abraham DJ
    Exp Cell Res; 2000 Aug; 259(1):213-24. PubMed ID: 10942593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype.
    Rueda B; Simeon C; Hesselstrand R; Herrick A; Worthington J; Ortego-Centeno N; Riemekasten G; Fonollosa V; Vonk MC; van den Hoogen FH; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Gonzalez-Escribano MF; Coenen MJ; Lambert N; Nelson JL; Radstake TR; Martin J
    Ann Rheum Dis; 2009 Oct; 68(10):1618-20. PubMed ID: 19054816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of connective tissue growth factor promoter polymorphism in Thai children with biliary atresia.
    Sa-nguanmoo P; Vejchapipat P; Chongsrisawat V; Chirathaworn C; Honsawek S; Theamboonlers A; Poovorawan Y
    J Med Assoc Thai; 2007 Feb; 90(2):251-7. PubMed ID: 17375628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts.
    Abraham DJ; Shiwen X; Black CM; Sa S; Xu Y; Leask A
    J Biol Chem; 2000 May; 275(20):15220-5. PubMed ID: 10809757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration.
    Bogatkevich GS; Ludwicka-Bradley A; Singleton CB; Bethard JR; Silver RM
    Am J Physiol Lung Cell Mol Physiol; 2008 Oct; 295(4):L603-11. PubMed ID: 18676875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
    Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
    Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothesis: pathogenesis of systemic sclerosis.
    Takehara K
    J Rheumatol; 2003 Apr; 30(4):755-9. PubMed ID: 12672195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression.
    Sternlicht MD; Dunning AM; Moore DH; Pharoah PD; Ginzinger DG; Chin K; Gray JW; Waldman FM; Ponder BA; Werb Z
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2107-14. PubMed ID: 17119035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between a CTGF gene polymorphism and systemic sclerosis in a French population.
    Granel B; Argiro L; Hachulla E; Fajardy I; Weiller PJ; Durand JM; Frances Y; Dombey AM; Marquet S; Lesavre N; Disdier P; Bernard F; Hatron PY; Chevillard C
    J Rheumatol; 2010 Feb; 37(2):351-8. PubMed ID: 20032097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis.
    Igarashi A; Nashiro K; Kikuchi K; Sato S; Ihn H; Grotendorst GR; Takehara K
    J Invest Dermatol; 1995 Aug; 105(2):280-4. PubMed ID: 7636314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resequencing of the characterised CTGF gene to identify novel or known variants, and analysis of their association with diabetic nephropathy.
    McKnight AJ; Savage DA; Patterson CC; Brady HR; Maxwell AP
    J Hum Genet; 2006; 51(4):383-386. PubMed ID: 16501850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.
    Hong KH; Yoo SA; Kang SS; Choi JJ; Kim WU; Cho CS
    Clin Exp Immunol; 2006 Nov; 146(2):362-70. PubMed ID: 17034590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the CTGF -945C/G polymorphism and systemic sclerosis: a meta-analysis.
    Zhang X; Nie S; Si X; Luo Y; Tang W
    Gene; 2012 Nov; 509(1):1-6. PubMed ID: 22906474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort.
    Bossini-Castillo L; Broen JC; Simeon CP; Beretta L; Vonk MC; Ortego-Centeno N; Espinosa G; Carreira P; Camps MT; Navarrete N; González-Escribano MF; Vicente-Rabaneda E; Rodríguez L; Tolosa C; Román-Ivorra JA; Gómez-Gracia I; García-Hernández FJ; Castellví I; Gallego M; Fernández-Nebro A; García-Portales R; Egurbide MV; Fonollosa V; de la Peña PG; Pros A; González-Gay MA; Hesselstrand R; Riemekasten G; Witte T; Coenen MJ; Koeleman BP; Houssiau F; Smith V; de Keyser F; Westhovens R; De Langhe E; Voskuyl AE; Schuerwegh AJ; Chee MM; Madhok R; Shiels P; Fonseca C; Denton C; Claes K; Padykov L; Nordin A; Palm O; Lie BA; Airó P; Scorza R; van Laar JM; Hunzelmann N; Kreuter A; Herrick A; Worthington J; Radstake TR; Martín J; Rueda B
    Ann Rheum Dis; 2011 Apr; 70(4):638-41. PubMed ID: 21187296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.